Results 151 to 160 of about 8,385,867 (288)

Susceptibility of Clinical Isolates of Cytomegalovirus to Human Interferon

, 1977
Bosko Postic, John Dowling
openalex   +1 more source

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic‐Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation

Clinical Pharmacology &Therapeutics, EarlyView.
Alemtuzumab is a T cell‐depleting monoclonal antibody that is used for the prevention of kidney transplant rejection. The duration of lymphodepletion after the current standard induction therapy dose is likely longer than necessary, resulting in prolonged T cell lymphopenia with the associated risk of infections. Here, the interplay between alemtuzumab
Lukas K. van Vugt, Tom C. Zwart, Suzanne Bezstarosti, Sebastiaan Heidt, Marlies E. J. Reinders, Dennis A. Hesselink, Aiko P. J. de Vries, Brenda C. M. de Winter, Dirk Jan A. R. Moes   +8 more
wiley   +1 more source

Association between human cytomegalovirus infection and incidence of severe orofacial clefts: a series of rare cases. [PDF]

BMC Oral Health
Abd-El-Ghafour M.
europepmc   +1 more source

Cytomegalovirus Latency in Cultured Human Cells

, 1973
Éva Gönczöl, L Váczi
openalex   +1 more source

Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity

Journal of Virology, 2017
W. Britt
semanticscholar   +1 more source

OMIP‐115: High‐Dimensional Phenotypic Characterization of Human Natural Killer Cells for Therapeutic Use

Cytometry Part A, EarlyView.
ABSTRACT This 29‐color flow cytometry panel was developed and optimized for in‐depth characterization of human peripheral blood NK cells for preclinical development and monitoring of NK cell therapies. The panel includes markers associated with NK cell differentiation, cytotoxicity, tissue residency, as well as NK cell dysfunction.
Emil Birch Christensen, Moritz Schaefer, Mike Bogetofte Barnkob, Christian Nielsen, Torben Barington   +4 more
wiley   +1 more source

Complex roles for proliferating cell nuclear antigen in restricting human cytomegalovirus replication. [PDF]

mBio
Longmire P, Daigle O, Zeltzer S, Lee M, Svoboda M, Padilla-Rodriguez M, Bobak C, Bosco G, Goodrum F.   +8 more
europepmc   +1 more source

Cell Cycle-dependent Chronic Infection of Human Cytomegalovirus in Human Osteogenic Sarcoma Cells

, 1979
Toru Furukawa
openalex   +1 more source

Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150

Science, 2017
Xuekui Yu, J. Jih, Jiansen Jiang, Z. H. Zhou   +3 more
semanticscholar   +1 more source

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Drug Testing and Analysis, EarlyView.
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario  Thevis, Tiia  Kuuranne, Hans  Geyer   +2 more
wiley   +1 more source